All Type of News
Tax exemptions set for facility spending
Tax breaks will be differently given for the corporate investment in upgrading the quality control of drugmakers’ production facility.
According to the revised tax code released by the Ministry of Strategy and Fina...
MSD Korea names new director for Diversified Business UnitMSD Korea, the subsidiary of the U.S. pharmaceutical firm Merck & Co., announced today that Lim Kwang-heok was appointed director of its Diversified Business Unit as of Aug. 5, ...
|
Korea's improved version of Nexium obtains final approval from US FDA
An incrementally modified (IMD) drug developed by a Korean drug company that treats gastro-esophageal reflex disease has received a final approval from the U.S. Food and Drug Administration (FDA) for the first time.
...
Drugmakers, wholesalers suffer from 3 trillion won losses due to returned medicine in 2012
Returned medicine has been still a headache for drug makers and wholesalers as they posted a loss of 3.18 trillion won due to returned goods last year, a government report showed recently.
According to the report b...
45 wholesalers supplying medicinal products of more than 100 billion won in 2012
The country’s 45 wholesalers, 46 drug firms and 12 importers were engaged in distributing pharmaceutical products amounting to over 100 billion won annually to hospitals and pharmacies last year, according to a report...
Proper medical fee will help emergency patient services
Korea should improve the current low-fee system for medical treatment covered by National Health Insurance to improve emergency patient services, a private report showed recently.
According to a report by the Korea...
Government to overhaul health insurance system
The National Health Insurance Corporation (NHIC) has come up with a plan to revamp the health insurance system.
The NHIC chief Kim Chong-dae renewed his strong will, via his social network service (SNS) on Monday, ...
Celltrion to conduct clinical trials for Remsima in the U.S.
Celltrion said Monday it has filed an application of its antibody drug Remsima for the U.S. Food and Drug Administration in a bid to carry out its clinical tests there.
It will take about six months to receive the ...
Drug output drops 1.4% in 2012
Korea’s total output of finished drugs declined 1.4 percent on-year in 2012, government report showed Tuesday.
According to a report released by the Health Insurance Review and Assessment Service (HIRA), the countr...
A wholesaler distributes drugs worth of 11.6 billion won in 2012
A drug wholesaler supplied pharmaceuticals worth of 11.6 billion won to hospitals and pharmacy last year, down 700 million won from 2011, a government report showed Tuesday.
According to a report by the Health Insu...
